Neurotherapeutic azole compounds

Details Neurotherapeutic azole compounds Neurotherapeutic azole compounds

2006-04-20

2009-10-06

Shameem, Golam M. M. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S281000, C514S283000, C548S250000, C548S255000, C548S262200

Reexamination Certificate

active

07598279

ABSTRACT:
Azole compounds containing carbamoyl group and pharmaceutically useful salts thereof are described. The compounds are effective anticonvulsants which are used in the treatment of disorders of the central nervous system, especially as anxiety, depression, convulsion, epilepsy, migraine, bipolar disorder, drug abuse, smoking, ADHD, obesity, sleep disorder, neuropathic pain, stroke, cognitive impairment, neurodegeneration, stroke and muscle spasm.

REFERENCES:
patent: 3415840 (1968-12-01), Wolf
patent: 5100916 (1992-03-01), Johansson et al.
patent: 6770659 (2004-08-01), Choi et al.
patent: WO 2006/112685 (2006-10-01), None
International Search Report issued for the corresponding PCT application No. PCT/KR2006/001523.
Written Opinion of the International Search Report issued for the corresponding PCT application No. PCT/KR2006/001523.
Karakurt et al., “Synthesis of some 1-(2-naphthyl)-2-(imidazole-1-yl)ethanone oxime and oxime ether derivatives and their anticonvulsant and antimicrobial activities,” Eur. J. Med. Chem. May 2001; 36(5): 421-433.

Affiliated with

Also associated with

Rating

Neurotherapeutic azole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neurotherapeutic azole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurotherapeutic azole compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4124850